We are live on ! Find out more
CMPX icon

Compass Therapeutics
CMPX

38 hedge funds and large institutions have $104M invested in Compass Therapeutics in 2022 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 11 increasing their positions, 3 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

267% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 3

125% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 4

12% more funds holding

Funds holding: 34 → 38 (+4)

5.62% more ownership

Funds ownership: 61.11% → 66.73% (+5.6%)

2% less capital invested

Capital invested by funds: $106M → $104M (-$2.07M)

60% less funds holding in top 10

Funds holding in top 10: 5 → 2 (-3)

Holders
38
Holders Change
+4
Holders Change %
+11.76%
% of All Funds
0.65%
Holding in Top 10
2
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-60%
% of All Funds
0.03%
New
9
Increased
11
Reduced
3
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$10.2M
2
EAM
Eventide Asset Management
Massachusetts
+$3.05M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$2.43M
4
BlackRock
BlackRock
New York
+$1.96M
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$1.6M

Top Sellers

1
CCM
Consonance Capital Management
New York
-$4.22M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$1.43M
3
CM
CM Management
Florida
-$80K
4
MWM
Mascoma Wealth Management
New Hampshire
-$42K
5
DCM
DAFNA Capital Management
California
-$27.7K
Name Holding Trade Value Shares
Change 		Change in
Stake
NCM
26
New Capital Management
Texas
$55K – – –
Bank of New York Mellon
27
Bank of New York Mellon
New York
$55K +$67.1K +24,251 New
O
28
OrbiMed
New York
$50.1K – – –
Susquehanna International Group
29
Susquehanna International Group
Pennsylvania
$45K +$54.6K +19,738 New
Jane Street
30
Jane Street
New York
$33K +$39.5K +14,265 New
FHA
31
Flagship Harbor Advisors
Massachusetts
$32K – – –
Morgan Stanley
32
Morgan Stanley
New York
$20K +$22.9K +8,259 +1,347%
UBS Group
33
UBS Group
Switzerland
$16K – – –
Citigroup
34
Citigroup
New York
$10K +$8.76K +3,163 +231%
Royal Bank of Canada
35
Royal Bank of Canada
Ontario, Canada
$2K +$1.24K +447 +196%
Barclays
36
Barclays
United Kingdom
$1K +$1.03K +374 New
Wells Fargo
37
Wells Fargo
California
$1K +$1.26K +457 New
CCM
38
Consonance Capital Management
New York
– -$4.22M -1,603,789 Closed
CM
39
CM Management
Florida
– -$80K -30,000 Closed
MWM
40
Mascoma Wealth Management
New Hampshire
– -$42K -15,682 Closed
COCM
41
Charter Oak Capital Management
New Hampshire
– -$4K -1,483 Closed
1
2

CMPX Hedge Fund Activity: Q3 2022 in Review

38 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Compass Therapeutics (CMPX) for Q3 2022, worth a combined $104M — down 2% from $106M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new CMPX positions and 4 closed out — a net gain of 5 holders — while 11 added to existing stakes and 3 trimmed.

The largest buyer was Janus Henderson Group, adding an estimated $10.2M. The largest seller was Consonance Capital Management, exiting entirely with an estimated $4.22M sold.

  • 38 institutional investors held Compass Therapeutics (CMPX) as of Q3 2022, up from 34 in Q2 2022.
  • Funds reported $104M of Compass Therapeutics stock for Q3 2022, down 2% quarter-over-quarter.
  • 9 funds opened new Compass Therapeutics positions in Q3 2022 and 4 closed out, a net change of +5 holders.
  • The largest Compass Therapeutics buyer in Q3 2022 was Janus Henderson Group, an estimated $10.2M added.
  • The largest Compass Therapeutics seller in Q3 2022 was Consonance Capital Management, an estimated $4.22M sold.

Based on aggregated 13F filings for Q3 2022.